SUMMARY Because of the possible clinical association between coeliac disease and sarcoidosis, the incidence of humoral sensitivity to dietary proteins was examined in patients with sarcoidosis. Raised concentrations of circulating IgG antibodies to alpha gliadin were found in 41/99 sarcoid patients whereas antibody levels to casein, beta lactaglobulin and ovalbumen were similar to normal controls. Subsequently, a group of 26 sarcoid patients were selected for small intestinal biopsy; 11 had raised and 15 normal alpha gliadin antibody (AGA) levels. One AGA positive patient had villous atrophy consistent with coeliac disease. Intraepithelial lymphocyte (IEL) counts were raised in AGA positive (median 30; 95% confidence limits 22-46) and AGA negative (median 24; 95% confidence limits 19-32) sarcoid patients when compared with a control group (median 13.5; 95% confidence limits 10-18) p<001. Serum IgG concentrations were raised in 11/52 patients tested but there was no correlation between IgG levels and the presence ofIgG antigliadin antibodies. HLA 
SUMMARY Because of the possible clinical association between coeliac disease and sarcoidosis, the incidence of humoral sensitivity to dietary proteins was examined in patients with sarcoidosis. Raised concentrations of circulating IgG antibodies to alpha gliadin were found in 41/99 sarcoid patients whereas antibody levels to casein, beta lactaglobulin and ovalbumen were similar to normal controls. Subsequently, a group of 26 sarcoid patients were selected for small intestinal biopsy; 11 had raised and 15 normal alpha gliadin antibody (AGA) levels. One AGA positive patient had villous atrophy consistent with coeliac disease. Intraepithelial lymphocyte (IEL) counts were raised in AGA positive (median 30; 95% confidence limits 22-46) and AGA negative (median 24; 95% confidence limits 19-32) sarcoid patients when compared with a control group (median 13.5; 95% confidence limits 10-18) p<001. Serum IgG concentrations were raised in 11/52 patients tested but there was no correlation between IgG levels and the presence ofIgG antigliadin antibodies. HLA The significance of these findings is unclear. As coeliac disease and sarcoidosis are both common in Ireland'3 14 and may be clinically associated,3 the raised AGAs and raised IEL counts may indicate a subpopulation which is genetically predisposed to having coeliac disease. This is unlikely, however, as the prevalence of HLA Dr3, which is found in 90% of coeliac patients,' was not increased in our sarcoid patients compared with Irish blood donors. Furthermore there was no association between Dr3 and either raised AGAs or raised IELs in the test group. It is possible that the humoral response to a dietary protein and increased IEL counts are epiphenomena of sarcoidosis which reflect general activation of the mucosal immune system. The recent observations, however, that patients with Crohn's disease have sarcoid like lymphocytosis of the lower respiratory tract'3 and that patients with coeliac disease frequently suffer from pulmonary disease,'6 in conjunc- tion with our results, suggests that immunological events in the gastrointestinal mucosa may play a primary pathogenic role in the development of sarcoidosis. This is supported by recent evidence of a common mucosal immune system in man'7 and by evidence that the antigen in pulmonary sarcoidosis may reach the lungs via the blood stream rather than through the airways.' Moreover, specific sensitisation to wheat protein in the absence of raised antibody levels to other dietary proteins suggests that gluten may have a specific aetiological role in a proportion of sarcoid patients. If this is the case a gluten free diet will be of therapeutic value in this group and controlled clinical trials to evaluate this therapy are needed.
